The Cleveland Clinic has granted an Austrian drug developer an exclusive option to license multiple compounds that Clinic researchers are developing to fight cancer.
Cleveland Clinic gives Austrian drug firm exclusive option to license compounds
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.